List of insiders holdings for Akero Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner |
2021-06-30 16:31:38 | 5,830,203 0 |
5,830,203 | Form 4 |
| 2 | Royston Aaron Director |
2019-06-25 18:05:51 | 0 3,954,858 |
3,954,858 | Form 4 |
| 3 | Bitterman Kevin Director |
2021-06-03 20:07:04 | 0 2,232,251 |
2,232,251 | Form 4 |
| 4 | Graham G. Walmsley Director |
2025-03-27 19:42:13 | 2,168 1,200,000 |
1,202,168 | Form 4 |
| 5 | Redmile Group LLC Green Jeremy 10% Owner |
2024-02-14 16:26:22 | 1,109,476 0 |
1,109,476 | Form 13G |
| 6 | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner |
2021-02-12 20:41:58 | 777,727 0 |
777,727 | Form 13G |
| 7 | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner |
2022-09-15 17:00:25 | 714,000 0 |
714,000 | Form 13D |
| 8 | Cheng Andrew President and CEO |
2025-04-11 18:00:05 | 624,324 0 |
624,324 | Form 4 |
| 9 | Atlas Venture Fund XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates XI L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. 10% Owner |
2023-02-14 16:31:15 | 467,529 0 |
467,529 | Form 13G |
| 10 | Atlas Venture Fund XI L.P. 10% Owner |
2023-02-14 16:31:15 | 467,529 0 |
467,529 | Form 13G |
| 11 | Atlas Venture Opportunity Fund I L.P. 10% Owner |
2020-02-10 19:49:53 | 0 454,589 |
454,589 | Form 4 |
| 12 | Young Jonathan Chief Operating Officer |
2025-03-14 20:33:23 | 200,540 60,000 |
260,540 | Form 4 |
| 13 | Rolph Timothy Chief Scientific Officer |
2025-04-10 18:00:04 | 198,439 0 |
198,439 | Form 4 |
| 14 | Yale Catriona Chief Development Officer |
2025-04-16 18:00:05 | 115,034 0 |
115,034 | Form 4 |
| 15 | Lamy Patrick Senior VP, Commercial Strategy |
2025-03-05 18:55:37 | 111,674 0 |
111,674 | Form 4 |
| 16 | Gangloff Scott A. Chief Technology Officer |
2024-12-18 20:56:09 | 98,000 0 |
98,000 | Form 4 |
| 17 | White William Richard Chief Financial Officer |
2025-03-14 20:24:56 | 61,959 0 |
61,959 | Form 4 |
| 18 | Iwicki Mark T Director |
2024-06-11 17:28:06 | 26,000 0 |
26,000 | Form 4 |
| 19 | Xu Yuan Director |
2024-06-11 17:31:05 | 26,000 0 |
26,000 | Form 4 |
| 20 | Heyman Tomas J. Director |
2024-06-11 17:25:32 | 26,000 0 |
26,000 | Form 4 |
| 21 | Henderson Jane Director |
2024-06-11 17:24:20 | 26,000 0 |
26,000 | Form 4 |
| 22 | Harrison Seth Loring Director |
2024-06-11 17:22:56 | 26,000 0 |
26,000 | Form 4 |
| 23 | Judy Chou Director |
2024-06-11 17:20:52 | 26,000 0 |
26,000 | Form 4 |
| 24 | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd Former 10% owner |
2023-09-12 16:30:42 | 0 0 |
0 | Form 13G |